{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:34Z","timestamp":1786119394848,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1097\/mbc.0000000000000798","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T22:50:44Z","timestamp":1552431044000},"page":"161-167","source":"Crossref","is-referenced-by-count":0,"title":["Case report of two siblings with type 2A von Willebrand disease involving a novel mutation within the calcium-binding site of the A2 domain of von Willebrand factor"],"prefix":"10.1097","volume":"30","author":[{"given":"Henry P.","family":"Igid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyaw Z.","family":"Thein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Castine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P.","family":"Quick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210203","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0025-6196(12)62088-6","article-title":"von Willebrand factor: clinical features of inherited and acquired disorders","volume":"66","author":"Bloom","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"R2-5-20210203","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand's disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"key":"R3-5-20210203","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"R4-5-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02981973","article-title":"Molecular genetics of type 2 von Willebrand disease","volume":"75","author":"Fressinaud","year":"2002","journal-title":"Int J Hematol"},{"key":"R6-5-20210203","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R7-5-20210203","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2014-08-528398","article-title":"Diagnostic approach to von Willebrand disease","volume":"125","author":"Ng","year":"2015","journal-title":"Blood"},{"key":"R8-5-20210203","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI115376","article-title":"Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit","volume":"88","author":"Dent","year":"1991","journal-title":"J Clin Invest"},{"key":"R9-5-20210203","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood-2012-09-455089","article-title":"VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease","volume":"121","author":"Eikenboom","year":"2013","journal-title":"Blood"},{"key":"R10-5-20210203","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1182\/blood-2014-09-603241","article-title":"von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease","volume":"125","author":"Sanders","year":"2015","journal-title":"Blood"},{"key":"R11-5-20210203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2141.2004.05009.x","article-title":"Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease","volume":"126","author":"Mannucci","year":"2004","journal-title":"Br J Haematol"},{"key":"R12-5-20210203","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2002-03-0814","article-title":"Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin","volume":"101","author":"Reiter","year":"2003","journal-title":"Blood"},{"key":"R13-5-20210203","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"R17-5-20210203","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"R18-5-20210203","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat Protoc"},{"key":"R19-5-20210203","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1101\/gr.176601","article-title":"Predicting deleterious amino acid substitutions","volume":"11","author":"Ng","year":"2001","journal-title":"Genome Res"},{"key":"R20-5-20210203","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat Methods"},{"key":"R21-5-20210203","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.1170905","article-title":"Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor","volume":"324","author":"Zhang","year":"2009","journal-title":"Science"},{"key":"R22-5-20210203","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1182\/blood-2009-12-257949","article-title":"The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain function","volume":"115","author":"Luken","year":"2010","journal-title":"Blood"},{"key":"R23-5-20210203","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1182\/blood-2015-09-672014","article-title":"N-linked glycan stabilization of the VWF A2 domain","volume":"127","author":"Lynch","year":"2016","journal-title":"Blood"},{"key":"R24-5-20210203","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ncomms1385","article-title":"Calcium modulates force sensing by the von Willebrand factor A2 domain","volume":"2","author":"Jakobi","year":"2011","journal-title":"Nat Commun"},{"key":"R25-5-20210203","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations","volume":"267","author":"Lyons","year":"1992","journal-title":"J Biol Chem"},{"key":"R26-5-20210203","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1182\/blood-2010-11-321596","article-title":"A novel calcium-binding site of von Willebrand factor A2 domain regulates its cleavage by ADAMTS13","volume":"117","author":"Zhou","year":"2011","journal-title":"Blood"},{"key":"R27-5-20210203","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0609.1993.tb00602.x","article-title":"Two new candidate mutations in type IIA von Willebrand's disease (Arg834-->Gly, Gly846-->Arg) and one polymorphism (Tyr821-->Cys) in the A2 region of the von Willebrand factor","volume":"51","author":"Donner","year":"1993","journal-title":"Eur J Haematol"},{"key":"R28-5-20210203","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-0038-1650564","article-title":"A novel mutation Gly 1672-->Arg in type 2A and a homozygous mutation in type 2B von Willebrand disease","volume":"76","author":"Hagiwara","year":"1996","journal-title":"Thromb Haemost"},{"key":"R29-5-20210203","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1055\/s-0038-1648511","article-title":"Characterization of three mutations causing von Willebrand disease type IIA in five unrelated families","volume":"67","author":"Inbal","year":"1992","journal-title":"Thromb Haemost"},{"key":"R30-5-20210203","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1055\/s-0038-1648510","article-title":"Three distinct candidate point mutations of the von Willebrand factor gene in four patients with type IIA von Willebrand disease","volume":"67","author":"Sugiura","year":"1992","journal-title":"Thromb Haemost"},{"key":"R31-5-20210203","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood.V82.3.830.830","article-title":"Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization method","volume":"82","author":"Inbal","year":"1993","journal-title":"Blood"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MBC.0000000000000798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:03:16Z","timestamp":1786039396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-201906000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000000798","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}